Company intelligence / Profile preview

Nextech Venture

Zurich, Switzerland

Ownership: Private
Employees: ~19
Development stage: Other

Overview

Nextech Invest is a therapeutics-focused venture capital firm that invests in drug discovery companies, primarily in oncology and adjacent diseases, from inception to public financings. It manages funds like Nextech V Oncology and has made investments in companies such as ORIC Pharmaceuticals, Tracon Pharmaceuticals, MacroGenics, Be Bio, and portfolio exits including Ganymed Pharmaceuticals.

Industry: Investors

Beyond the preview

Go deeper on Nextech Venture.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nextech Venture.

Explore the full profile